Pregnancy Clinical Trial
Official title:
LIFT: Lifestyle Interventions For Two (Member of the LIFE Moms Consortium)
This randomized, controlled trial is proposed to study the effect, in a cohort of racially and ethnically diverse group of overweight and obese pregnant women, of an Intensive Lifestyle Intervention (ILI) which utilize cognitive behavioral strategies to help participants achieve and maintain changes in dietary intake and physical activity habits compared to Usual Care (UC) on gestational weight gain (GWG), infant fatness, and mothers' post-delivery weight retention. The hypothesis is that the percent body fat at birth will be significantly less in offspring from ILI mothers than UC mothers.
Overall body weight and weight gain during pregnancy have gone up among all women in the
United States. Higher body weight of the mother at the time of the baby's conception and a
greater weight gain during pregnancy are both associated with more fat in the infant and
later overweight in children. Obesity in children has become a great public health problem.
This study will use the new Institute of Medicine Guidelines for weight gain during
pregnancy. These Guidelines are based on observations showing that women whose weight gain
was within the recommended Guidelines had healthier pregnancies and better pregnancy outcomes
than those who did not follow the Guidelines. It is important for researchers to understand
whether a lifestyle intervention like LIFT can help women have healthier pregnancies and
healthier babies. If the researchers find that a lifestyle intervention positively impacts
the mothers and their babies, then the researchers can help other pregnant women have
healthier pregnancies and babies as well.
This Study, The Lifestyle Intervention For Two (LIFT) Study, is part of the LIFE Moms
consortium, a national project involving seven sites across the US. The purpose of the LIFE
Moms consortium is to study different ways in which women who are overweight or obese can
manage their body weight during pregnancy, and how this may affect them and their baby's
health at birth and through the first year. As part of the LIFE Moms consortium, The LIFT
Study will look how controlled weight gain during pregnancy will impact the health of the
mother and her child. Researchers at Columbia University are investigating the effect of an
intensive lifestyle intervention (i.e. diet and physical activity counseling). The
researchers hope to positively impact not only body weight gain during pregnancy, but also
positively impact infant body fatness and mother's weight loss after pregnancy. The LIFE Moms
researchers are looking at whether too much weight gain in the mother will result in a leaner
baby, and less retention of fat by the mother following pregnancy.
This study is a randomized controlled trial to study the effect, in a cohort of racially and
ethnically diverse group of overweight and obese pregnant women, of an Intensive Lifestyle
Intervention (ILI) compared to Usual Care (UC) on gestational weight gain (GWG), infant
fatness, and mothers' post-delivery weight retention. Women in the ILI arm will receive
intensive counseling during pregnancy and group counseling after delivery regarding behavior,
nutrition, and physical activity change. Visits to counselors will occur semi-monthly and
additional telephone and internet contacts will occur. The mothers' will be assessed at 14
and 36 weeks of pregnancy and at 14 weeks (range 13-15) and 52 (range 48-56) weeks
post-delivery. The measurements will be anthropometry, whole body MRI, EchoMRI, and whole
body plethysmography (BodPod). The infants' measurements will be anthropometry, whole body
MRI, EchoMRI, and whole body plethysmography (PeaPod) for fatness 14 weeks (range 14-15)
weeks and 52 (range 48-56) weeks. Mothers and children will have cardio-metabolic risk
factors measured in plasma. Data will be collected regarding mothers' dietary intake and
physical activity (questionnaires and accelerometry) to assist in counseling. Other data to
be collected include questionnaires on quality of life, socio-economic status. Each mother
will be followed during pregnancy and for a year post delivery. Each infant will be followed
for a year after birth. The researchers have the ability to continue to follow these
participants if further funding is forthcoming, as they are all local to the hospital's
catchment area and to own physicians.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02528136 -
The Clinical Carbetocin Myocardium Trial
|
Phase 4 |